Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Inappropriate Use of Proton Pump Inhibitors for Stress Ulcer Prophylaxis

Article PDF
Author and Disclosure Information

Martin Ziska, PharmD, BS; Nicole L. McMaster-Baxter, PharmD, MS, BCPS; and Richard M. Cadle, PharmD, BCPS, FASHP

Dr. Ziska is a clinical pharmacist in geriatrics at the Audie L. Murphy Memorial Veterans Hospital in San Antonio, Texas. At the time of this study, he was a pharmacy practice resident at the Michael E. DeBakey VA Medical Center (MEDVAMC) in Houston, Texas. Dr. McMaster-Baxter is a clinical pharmacy specialist in internal medicine at the MEDVAMC; an instructor in the section of internal medicine at Baylor College of Medicine (BCM) in Houston, Texas; and a clinical assistant professor at the University of Texas in Austin and the University of Houston in Houston, Texas. Dr. Cadle is the clinical pharmacy manager, pharmacy residency program director, and an infectious disease clinical pharmacy specialist in the MEDVAMC; an assistant professor of medicine in the infectious diseases section at BCM; and a clinical assistant professor at the University of Texas in Austin and the University of Houston.

Issue
Federal Practitioner - 28(2)
Publications
Page Number
27
Legacy Keywords
Stress ulcer prophylaxis, proton pump inhibitors, cost, Clostridium difficile, Stress-related mucosal disease, SRMD, ulcerations, gastrointestinal submucosa, splanchnic hypoperfusion, gastrointestinal bleeding, respiratory failure, PPI, CDADStress ulcer prophylaxis, proton pump inhibitors, cost, Clostridium difficile, Stress-related mucosal disease, SRMD, ulcerations, gastrointestinal submucosa, splanchnic hypoperfusion, gastrointestinal bleeding, respiratory failure, PPI, CDAD
Sections
Author and Disclosure Information

Martin Ziska, PharmD, BS; Nicole L. McMaster-Baxter, PharmD, MS, BCPS; and Richard M. Cadle, PharmD, BCPS, FASHP

Dr. Ziska is a clinical pharmacist in geriatrics at the Audie L. Murphy Memorial Veterans Hospital in San Antonio, Texas. At the time of this study, he was a pharmacy practice resident at the Michael E. DeBakey VA Medical Center (MEDVAMC) in Houston, Texas. Dr. McMaster-Baxter is a clinical pharmacy specialist in internal medicine at the MEDVAMC; an instructor in the section of internal medicine at Baylor College of Medicine (BCM) in Houston, Texas; and a clinical assistant professor at the University of Texas in Austin and the University of Houston in Houston, Texas. Dr. Cadle is the clinical pharmacy manager, pharmacy residency program director, and an infectious disease clinical pharmacy specialist in the MEDVAMC; an assistant professor of medicine in the infectious diseases section at BCM; and a clinical assistant professor at the University of Texas in Austin and the University of Houston.

Author and Disclosure Information

Martin Ziska, PharmD, BS; Nicole L. McMaster-Baxter, PharmD, MS, BCPS; and Richard M. Cadle, PharmD, BCPS, FASHP

Dr. Ziska is a clinical pharmacist in geriatrics at the Audie L. Murphy Memorial Veterans Hospital in San Antonio, Texas. At the time of this study, he was a pharmacy practice resident at the Michael E. DeBakey VA Medical Center (MEDVAMC) in Houston, Texas. Dr. McMaster-Baxter is a clinical pharmacy specialist in internal medicine at the MEDVAMC; an instructor in the section of internal medicine at Baylor College of Medicine (BCM) in Houston, Texas; and a clinical assistant professor at the University of Texas in Austin and the University of Houston in Houston, Texas. Dr. Cadle is the clinical pharmacy manager, pharmacy residency program director, and an infectious disease clinical pharmacy specialist in the MEDVAMC; an assistant professor of medicine in the infectious diseases section at BCM; and a clinical assistant professor at the University of Texas in Austin and the University of Houston.

Article PDF
Article PDF

Issue
Federal Practitioner - 28(2)
Issue
Federal Practitioner - 28(2)
Page Number
27
Page Number
27
Publications
Publications
Article Type
Display Headline
Inappropriate Use of Proton Pump Inhibitors for Stress Ulcer Prophylaxis
Display Headline
Inappropriate Use of Proton Pump Inhibitors for Stress Ulcer Prophylaxis
Legacy Keywords
Stress ulcer prophylaxis, proton pump inhibitors, cost, Clostridium difficile, Stress-related mucosal disease, SRMD, ulcerations, gastrointestinal submucosa, splanchnic hypoperfusion, gastrointestinal bleeding, respiratory failure, PPI, CDADStress ulcer prophylaxis, proton pump inhibitors, cost, Clostridium difficile, Stress-related mucosal disease, SRMD, ulcerations, gastrointestinal submucosa, splanchnic hypoperfusion, gastrointestinal bleeding, respiratory failure, PPI, CDAD
Legacy Keywords
Stress ulcer prophylaxis, proton pump inhibitors, cost, Clostridium difficile, Stress-related mucosal disease, SRMD, ulcerations, gastrointestinal submucosa, splanchnic hypoperfusion, gastrointestinal bleeding, respiratory failure, PPI, CDADStress ulcer prophylaxis, proton pump inhibitors, cost, Clostridium difficile, Stress-related mucosal disease, SRMD, ulcerations, gastrointestinal submucosa, splanchnic hypoperfusion, gastrointestinal bleeding, respiratory failure, PPI, CDAD
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media